Abstract
Vasculitis often presents a diagnostic challenge as the disease processes may have varied presentations. This article reviews some vasculitis-like “mimics,” particularly emphasizing viral and bacterial infections, drug-related disorders, various malignancies, and other autoimmune disorders, all of which may have a similar clinical presentation. This article also highlights recent advances and the importance of accurate diagnosis and therapy.
Similar content being viewed by others
References and Recommended Reading
Stone JH: Vasculitides C. The antineutrophil cytoplasmic antibody-associated vasculitides: Wegener’s granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. In Primer on the Rheumatic Diseases, edn 13. Edited by Klippel JH, Stone JH, Crofford LJ, White PH. New York: Springer; 2008:416–426.
Jennette JC, Falk RJ: New insight into the pathogenesis of vasculitis associated antineutrophil cytoplasmic autoantibodies. Cur Opin Rheumatol 2008, 20:55–60.
Friedman DR, Wolfsthal SD: Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005, 5:671–673.
Trimarchi M, Gregorini G, Facchetti F, et al.: Cocaine induced midline destructive lesions: clinical, radiographic, histopathologic and serologic features and their differentiation from Wegener’s granulomatosis. Medicine (Baltimore) 2001, 80:391–404.
Weisner O, Russell KA, Lee AS, et al.: Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not auto-immune vasculitis. Arthritis Rheum 2004, 50:2954–2965.
Molloy ES, Langford CA: Vasculitis mimics. Cur Opin Rheumatol 2008, 20:29–34
Peikert T, Finkelman JD, Hummel AM, et al.: Functional characteristics of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions. Arthritis Rheum 2008, 58:1546–1551.
Molloy E, Hoffman G, Langford CA: Determining the cause of isolated midline destructive lesions: comment on the clinical images presented by Kasifoglu et al. Arthritis Rheum 2009, 60:632–633.
Orriols R, Muñoz X, Ferrer J, et al.: Cocaine-induced Churg Strauss vasculitis. Eur Respir J 1996, 9:175–177.
Bhinder SK, Majithia V: Cocaine use and its rheumatic manifestations: a case report and discussion. Clin Rheumatol 2007, 26:1192–1194.
Hofbrauer GF, Hafner J, Trüeb RM: Urticarial vasculitis following cocaine use. Br J Dermatol 1999, 141:600–601.
Chevalier X, Rostoker G, Larget-Piet B, Gherardi R: Schönlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 1995, 43:348–349.
Wiik A: Drug-induced vasculitis. Cur Opin Rheumatol 2008, 20:35–39.
Wiik A: Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results. Springer Semin Immunopathol 2001, 23:217–229.
Choi HK, Merkel PA, Walker AM, Niles JL: Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000, 43:405–413.
Röglin J, Böer A: Skin manifestations of intravascular lymphoma mimic inflammatory diseases of the skin. Br J Dermatol 2007, 157:16–25.
Valeriano-Marcet J, Bateman H: Rheumatology. In Visual Diagnosis, edn 3. Jupiter, FL: Merrit; 2009.
McIlwain L, Carter JD, Bin-Sagheer S, et al.: Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. J Clin Gastroenterol 2003, 36:411–413.
Mohan N, Edwards ET, Cupps TR, et al.: Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheum 2004, 31:1955–1958.
Seo P: Vasculitides D. Immune complex mediated vasculitis. In Primer on the Rheumatic Diseases, edn 13. Edited by Klippel JH, Stone JH, Crofford LJ, White PH. New York: Springer; 2008:427–434.
Guillevin L: Vasculitides in the context of HIV infection. AIDS 2008, 22(Suppl 3):S27–S33.
Gherardi R, Belec L, Mhiri C, et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 1993, 36:1164–1174.
Stegeman CA, Tervaert JW, Sluiter WJ, et al.: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener’s granulomatosis. Ann Intern Med 1994, 120:12–17.
Lapraik C, Watts R, Bacon P, et al.: BSR and BHPR Guidelines for the management of ANCA associated vasculitis. Rheumatology 2007, 46:1615–1616.
Choi HK, Lamprecht P, Niles JL, et al.: Subacute bacterial endocarditis with positive antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000, 43:226–231.
Grau R: Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep 2002, 4:83–89.
Dietz HC, Cutting GR, Pyeritz RE, et al.: Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991, 352:337–339.
Pepin M, Schwarze U, Superti-Furga A, Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000, 342:673–680.
Loeys BL, Chen J, Neptune ER, et al.: A syndrome of altered cardiovascular, craniofacial neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005, 37:275–281.
Grange DK, Balfour IC, Chen SC, Wood EG: Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. Am J Med Genet 1998, 75:469–480.
Libman BS, Quismorio FP Jr, Stimmler MM: Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. J Rheumatol 1995, 22:351–355.
Guillevin L: Virus-associated vasculitides. Rheumatology (Oxford) 1999, 38:588–590.
Choi JB, Yang HW, Oh SK, Yun KJ: Rupture of ascending aorta secondary to tuberculous aortitis. Ann Thorac Surg 2003, 75:1965–1967.
Lie JT: Segmental mediolytic arteritis: not an arteritis but a variant of arterial fibromuscular dysplasia. Arch Pathol Lab Med 1992, 116:238–241.
Lie JT: Systemic, cerebral, and pulmonary segmental mediolytic arteriopathy: villainous masqueraders of vasculitis. Cardiovasc Pathol 1996, 5:305–314.
Chan RJ, Goodman TA, Aretz TH, Lie JT: Segmental mediolytic arteriopathy of the splenic and hepatic arteries mimicking systemic necrotizing vasculitis. Arthritis Rheum 1998, 41:935–938.
Caus T, Canavy I, Mesana T, et al.: Rescue revascularization for acute coronary occlusion late after radiotherapy. Ann Thorac Surg 1999, 67:236–238.
Basavaraju SR, Easterly CE: Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 2002, 29:2391–2403.
Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB: Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007, 146:34–44.
Hajj-Ali RA, Singhal AB, Calabrese LH. Reversible cerebral vasoconstrictive syndrome [abstract] Arthritis Rheum 2008, 58(Suppl 9):S906.
Hajj-Ali RA, Furlan A, Abou-Chebel A, Calabrese LH: Benign angiopathy of the central nervous system: cohort of 16 patients with clinical course and long-term followup. Arthritis Rheum 2002, 47:662–669
Kossorotoff M, Touzé E, Godon-Hardy S, et al.: Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology 2006, 66:1121–1122.
Scully M, Yarranton H, Liesner R, et al.: Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 2008, 142:819–826.
Calabrese LH, Duna GF, Lie JT: Vasculitis in the central nervous system. Arthritis Rheum 1997, 40:1189–1201.
Lie JT: Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system. Arthritis Rheum 1992, 35:831–834.
O’sullivan M, Jarosz JM, Martin RJ, et al.: MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001, 56:628–634.
Weber T, Trebst C, Frye S, et al.: Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997, 176:250–254.
Calabrese LH, Molloy ES, Huang D, Ransohoff RM: Progressive multifocal leukoencephalopathy in rheumatic diseases: the evolving clinical and pathologic patterns of disease. Arthritis Rheum 2007, 56:2116–2128.
Molloy ES, Calabrese LH: Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk? Autoimmun Rev 2008, 8:144–146.
Bartynski WS: Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008, 29:1036–1042.
Min L, Zwerling J, Ocava LC, et al.: Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum 2006, 35:388–395.
Eng JA, Frosch MP, Choi K, et al.: Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004, 55:250–256.
Lower EE, Wiess KL: Neurosarcoidosis. Clin Chest Med 2008, 29:475–492.
Pozzi M, Roccatagliata D, Sterzi R: Drug abuse and intracranial hemorrhage. Neurol Sci 2008, 29:S269–S270.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bateman, H., Rehman, A. & Valeriano-Marcet, J. Vasculitis-like syndromes. Curr Rheumatol Rep 11, 422–429 (2009). https://doi.org/10.1007/s11926-009-0062-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-009-0062-9